These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10337717)

  • 1. Rationale and mechanisms of cancer chemoprevention.
    De Flora S; Bennicelli C; Bagnasco M
    Recent Results Cancer Res; 1999; 151():29-44. PubMed ID: 10337717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of inhibitors of mutagenesis and carcinogenesis.
    De Flora S
    Mutat Res; 1998 Jun; 402(1-2):151-8. PubMed ID: 9675264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple points of intervention in the prevention of cancer and other mutation-related diseases.
    De Flora S; Izzotti A; D'Agostini F; Balansky RM; Noonan D; Albini A
    Mutat Res; 2001 Sep; 480-481():9-22. PubMed ID: 11506795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of mechanisms of cancer chemopreventive agents.
    De Flora S; Ferguson LR
    Mutat Res; 2005 Dec; 591(1-2):8-15. PubMed ID: 16107270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Third International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis.
    De Flora S; Bronzetti G; Weisburger JH
    Cancer Epidemiol Biomarkers Prev; 1991; 1(1):95-9. PubMed ID: 1688263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and approaches to the prevention of smoking-related diseases: overview of recent studies on chemoprevention of smoking-induced tumors in rodent models.
    De Flora S; Izzotti A; D'Agostini F; La Maestra S; Micale RT; Ceccaroli C; Steele VE; Balansky R
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2014; 32(2):105-20. PubMed ID: 24875440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk biomarkers and current strategies for cancer chemoprevention.
    Kelloff GJ; Boone CW; Crowell JA; Nayfield SG; Hawk E; Malone WF; Steele VE; Lubet RA; Sigman CC
    J Cell Biochem Suppl; 1996; 25():1-14. PubMed ID: 9027592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanistic considerations in the evaluation of chemopreventive data.
    Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet RA; Greenwald P; Hawk ET; Fay JR; Sigman CC
    IARC Sci Publ; 1996; (139):203-19. PubMed ID: 8923032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of N-acetylcysteine in the prevention of DNA damage and cancer, with special reference to smoking-related end-points.
    De Flora S; Izzotti A; D'Agostini F; Balansky RM
    Carcinogenesis; 2001 Jul; 22(7):999-1013. PubMed ID: 11408342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA adducts and chronic degenerative disease. Pathogenetic relevance and implications in preventive medicine.
    De Flora S; Izzotti A; Randerath K; Randerath E; Bartsch H; Nair J; Balansky R; van Schooten F; Degan P; Fronza G; Walsh D; Lewtas J
    Mutat Res; 1996 Dec; 366(3):197-238. PubMed ID: 9033668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer chemoprevention by natural products: how far have we come?
    Mehta RG; Murillo G; Naithani R; Peng X
    Pharm Res; 2010 Jun; 27(6):950-61. PubMed ID: 20238150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as targets for dietary and pharmacological inhibitors of mutagenesis and carcinogenesis.
    Izzotti A; Cartiglia C; Steele VE; De Flora S
    Mutat Res; 2012; 751(2):287-303. PubMed ID: 22683846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanistic approaches to chemoprevention of mutation and cancer.
    Ferguson LR; Bronzetti G; De Flora S
    Mutat Res; 2005 Dec; 591(1-2):3-7. PubMed ID: 16095634
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The retinoids and cancer prevention mechanisms.
    Dragnev KH; Rigas JR; Dmitrovsky E
    Oncologist; 2000; 5(5):361-8. PubMed ID: 11040271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Way Forward for Cancer Chemoprevention: Think Local.
    Al Rabadi L; Bergan R
    Cancer Prev Res (Phila); 2017 Jan; 10(1):14-35. PubMed ID: 27780807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting signal transduction pathways by chemopreventive agents.
    Bode AM; Dong Z
    Mutat Res; 2004 Nov; 555(1-2):33-51. PubMed ID: 15476850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preventive medicine: biomonitoring and chemoprevention].
    Tompa A; Szende B
    Magy Onkol; 2002; 46(2):147-53. PubMed ID: 12202894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of genotoxic and related effects by carotenoids and vitamin A in experimental models: mechanistic issues.
    De Flora S; Bagnasco M; Vainio H
    Mutagenesis; 1999 Mar; 14(2):153-72. PubMed ID: 10229917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of chemoprevention in cancer control.
    Greenwald P; Kelloff GJ
    IARC Sci Publ; 1996; (139):13-22. PubMed ID: 8923016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surrogate endpoint biomarkers for phase II cancer chemoprevention trials.
    Kelloff GJ; Boone CW; Crowell JA; Steele VE; Lubet R; Doody LA
    J Cell Biochem Suppl; 1994; 19():1-9. PubMed ID: 7823579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.